Latest News

Todos COVID-19 Drug Shows Superiority to Remdesivir,Takes Dying Off the Table

February 9, 2022 ( Newswire) In a phase 2 clinical study, Todos Medical’s oral antiviral Tollovir showed a 100% reduction in mortality from COVID-19.

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *